Robert Andrade, the Chief Financial Officer of Fennec Pharmaceuticals Inc (NASDAQ:FENC), has sold 30,000 shares of the company on January 5, 2024, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Robert Andrade, the Chief Financial Officer of Fennec Pharmaceuticals Inc (NASDAQ:FENC), has sold 30,000 shares of the company on January 5, 2024, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles